{
    "organizations": [],
    "uuid": "433d22c145a4dd3eb4b05ee74d3c83a53a79a640",
    "author": "",
    "url": "https://www.reuters.com/article/brief-casi-pharmaceuticals-enters-into-a/brief-casi-pharmaceuticals-enters-into-a-common-stock-sales-agreement-with-h-c-wainwright-co-idUSFWN1QD1HM",
    "ord_in_thread": 0,
    "title": "BRIEF-Casi Pharmaceuticals Enters Into A Common Stock Sales Agreement With H.C. Wainwright & Co",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 23 (Reuters) - Casi Pharmaceuticals Inc:\n* CASI PHARMACEUTICALS INC SAYS ENTERED INTO A COMMON STOCK SALES AGREEMENT WITH H.C. WAINWRIGHT & CO LLC - SEC FILING\n* CASI PHARMACEUTICALS - AS PER STOCK SALES AGREEMENT, CO MAY SELL FROM TIME TO TIME SHARES OF CO'S STOCK THROUGH HCW WITH TOTAL SALES PRICE UP TO $25 MILLION Source text: ( bit.ly/2ENog5J ) Further company coverage:\n ",
    "published": "2018-02-24T00:36:00.000+02:00",
    "crawled": "2018-02-24T00:55:05.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "casi",
        "pharmaceutical",
        "inc",
        "casi",
        "pharmaceutical",
        "inc",
        "say",
        "entered",
        "common",
        "stock",
        "sale",
        "agreement",
        "wainwright",
        "co",
        "llc",
        "sec",
        "filing",
        "casi",
        "pharmaceutical",
        "per",
        "stock",
        "sale",
        "agreement",
        "co",
        "may",
        "sell",
        "time",
        "time",
        "share",
        "co",
        "stock",
        "hcw",
        "total",
        "sale",
        "price",
        "million",
        "source",
        "text",
        "company",
        "coverage"
    ]
}